Elite Pharmaceuticals Reports Positive Topline Results from a Pivotal Bioequivalence Study
May 30, 2017 12:57 pm UTC| Business
NORTHVALE, N.J., May 30, 2017 -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) today reported positive topline results from pivotal bioequivalence studies conducted in April of this year for an...
Centro Creates Private Marketplace Directory Curated with 1,000+ Deals in Demand-Side Platform
May 30, 2017 12:57 pm UTC| Business
CHICAGO, May 30, 2017 -- Centro (www.centro.net), a provider of enterprise-class software for digital advertising, today announced the creation of a private marketplace (PMP) directory curated with 1,000+ deals from...
Centro Creates Private Marketplace Directory Curated with 1,000+ Deals in Demand-Side Platform
May 30, 2017 12:57 pm UTC| Business
CHICAGO, May 30, 2017 -- Centro (www.centro.net), a provider of enterprise-class software for digital advertising, today announced the creation of a private marketplace (PMP) directory curated with 1,000+ deals from...
Centro Creates Private Marketplace Directory Curated with 1,000+ Deals in Demand-Side Platform
May 30, 2017 12:57 pm UTC| Business
CHICAGO, May 30, 2017 -- Centro (www.centro.net), a provider of enterprise-class software for digital advertising, today announced the creation of a private marketplace (PMP) directory curated with 1,000+ deals from...
Elite Pharmaceuticals Reports Positive Topline Results from a Pivotal Bioequivalence Study
May 30, 2017 12:55 pm UTC| Business
NORTHVALE, N.J., May 30, 2017 -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) today reported positive topline results from pivotal bioequivalence studies conducted in April of this year for an...
Elite Pharmaceuticals Reports Positive Topline Results from a Pivotal Bioequivalence Study
May 30, 2017 12:55 pm UTC| Business
NORTHVALE, N.J., May 30, 2017 -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) today reported positive topline results from pivotal bioequivalence studies conducted in April of this year for an...
Elite Pharmaceuticals Reports Positive Topline Results from a Pivotal Bioequivalence Study
May 30, 2017 12:55 pm UTC| Business
NORTHVALE, N.J., May 30, 2017 -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) today reported positive topline results from pivotal bioequivalence studies conducted in April of this year for an...
Viksit Bharat 2026: Fiscal Muscle, Factory Revival, and the War on Speculation